
Cortellis Regulatory Intelligence
AI-assisted regulatory intelligence for navigating global pharma compliance and strategic decision-making.
Overview
Cortellis Regulatory Intelligence is an AI-powered software platform from Clarivate designed to help pharmaceutical and life sciences professionals confidently navigate the complex global regulatory landscape. Trusted by top 20 pharma companies, it delivers expert-curated regulatory data and AI-assisted intelligence to support compliance management and strategic decision-making across international markets.
The platform is purpose-built for regulatory affairs teams, compliance professionals, and strategic decision-makers within the pharmaceutical and life sciences industries who need reliable, up-to-date regulatory information to guide their operations and submissions worldwide.
Core Capabilities
- AI-assisted regulatory intelligence to streamline the identification and interpretation of global regulatory requirements
- Expert-curated regulatory data ensuring accuracy and relevance across multiple jurisdictions
- Tools to confidently navigate the global pharma regulatory landscape with comprehensive coverage
- Support for maintaining ongoing compliance with evolving international regulatory standards
- Strategic decision-making support informed by up-to-date regulatory insights
Key Benefits
- Trusted by top 20 pharmaceutical companies, reflecting a high standard of data quality and platform reliability
- Reduces complexity in monitoring and responding to regulatory changes across global markets
- Enables proactive compliance management rather than reactive responses to regulatory updates
- Empowers regulatory teams to make well-informed, evidence-based strategic decisions
Cortellis Regulatory Intelligence is part of the broader Clarivate Cortellis suite of life sciences intelligence solutions, which includes complementary products such as Cortellis Drug Discovery Intelligence, Cortellis CMC Intelligence, and Cortellis Product Intelligence, allowing organisations to access integrated intelligence across the full pharmaceutical development and commercialisation lifecycle.
